A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease

Molecular Pharmacology - United States
doi 10.1124/mol.116.104687
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Aryl Hydrocarbon Receptor-Fibroblast Growth Factor 21 Dissociation of Fatty Liver From Insulin Resistance: A Timely Matter?

Hepatology
MedicineHepatology
2015English

Hepatic Nuclear Receptor Expression Associates With Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease

Hepatology Communications
Hepatology
2018English

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Thyroid Hormone Receptor Regulates Most Genes Independently of Fibroblast Growth Factor 21 in Liver

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Hepatic Connexin 32 Associates With Nonalcoholic Fatty Liver Disease Severity

Hepatology Communications
Hepatology
2018English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Nonalcoholic Fatty Liver Disease in 2020

Gastroenterology
HepatologyGastroenterology
2020English

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Hepatology
MedicineHepatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy